Pediatric Multi-Dose
Research payments
$910,230
Through program year 2024, $910,230 in research payments was reported against Pediatric Multi-Dose, across 137 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $150,199 | 15 |
| 2023 | Research | $61,369 | 5 |
| 2022 | Research | $51,851 | 7 |
| 2021 | Research | $183,687 | 23 |
| 2020 | Research | $145,782 | 31 |
| 2019 | Research | $317,343 | 56 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Katherine Dell Cleveland, OH Named on 16 payments
- Bradley Warady Kansas City, MO Named on 14 payments
- Corinne Benchimol New York, NY Named on 14 payments
- Raoul Nelson Salt Lake City, UT Named on 12 payments
- Gary Lerner Los Angeles, CA Named on 9 payments
- Pascale Lane Oklahoma City, OK Named on 7 payments
- Larysa Wickman Ann Arbor, MI Named on 5 payments
- Benjamin Laskin Philadelphia, PA Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.